Interestingly, the inhibition of IKZF1 by Lenalidomide leads to the cell death of myeloma cell death through the Cereblon (CRBN)-dependent ubiquitylation [16], indicating it may serve as a potential target in developing the strategies for MM treatment. This evidence concerns the gene IKZF1 and Miyoshi myopathy.